Keap1-Nrf2-IN-21
Product Specifications
Target
Nrf2
Related Pathways
Immunology/Inflammation
Bioactivity
Keap1-Nrf2-IN-21 (compound 4d) acts as an inhibitor of glucose metabolism with anti-tumoral properties. It targets the glycolytic pathway by affecting the Keap1-Nrf2 signaling pathway, which in turn suppresses glycolytic activity in cancer cells and inhibits tumor growth. Additionally, Keap1-Nrf2-IN-21 exhibits cytotoxic effects on the HEC1A cell line with an IC50 value of 2.60 μM.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
302776-ML490 100 µL
SSPN (Sarcospan, K-ras Oncogene-Associated Protein, Kirsten-ras-Associated Protein, SSPN, KRAG) (MaxLight 490) discontinued
Sign In for Pricing
View Details 